Specific immune responses after BNT162b2 mRNA vaccination and COVID-19 infection
Although vaccines against COVID-19 are effective tools in preventing severe disease, recent studies have shown enhanced protection after vaccine boosters. The aim of our study was to examine the dynamics and duration of both humoral and cellular immune responses following a three-dose regimen of the...
Main Authors: | Simona Arientová, Kateřina Matúšková, Oldřich Bartoš, Michal Holub, Ondřej Beran |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1271353/full |
Similar Items
-
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
by: Claudia Gandolfo, et al.
Published: (2022-01-01) -
Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Adults
by: Jonas Herzberg, et al.
Published: (2022-05-01) -
A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
by: Jan Melin, et al.
Published: (2022-10-01) -
Antibody response after two doses of the BNT162b2 vaccine among healthcare workers of a Greek Covid 19 referral hospital: A prospective cohort study
by: Areti Tychala, et al.
Published: (2022-05-01) -
Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222
by: Evangelos Terpos, et al.
Published: (2022-02-01)